Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers identify gene for most common paediatric malignant brain tumour

17.06.2002


Researchers at The Hospital for Sick Children (HSC), the University Health Network (UHN), and the University of Toronto (U of T) have identified a novel gene that when mutated results in medulloblastoma, the most common malignant brain tumour found in children. This research is reported in the July issue of the scientific journal Nature Genetics.



Brain tumours are the second most common cancer in children after leukemia, with the incidence increasing at a rate of five to 10 per cent per year. More than 200 Canadian children are diagnosed with brain tumours each year, with approximately 100 new cases at The Hospital for Sick Children alone. Despite advances in treatment, survival from brain tumours remains lower than for other forms of cancer. Medulloblastoma, a malignant tumour that occurs in the cerebellum, accounts for 20 per cent of all paediatric brain tumours. It is a rapidly growing tumour that is more common in boys than girls.

"A subset of children with medulloblastoma are born with a mutation in a gene called SUFU, or human suppressor of fused, that predisposes them to develop this tumour. This is a germline mutation - the mutation is in every cell of the child’s body - which indicates that this gene is important in the initiation of the tumour," said Dr. Michael Taylor, the study’s lead author, a U of T graduate student, and a neurosurgery resident in HSC’s Clinician-Scientist Training Program.


The mutated gene has lost the ability to suppress two signaling pathways (Hedgehog and Wnt) that are important in normal brain development. In children with a mutated SUFU gene, the brain cells grow too rapidly causing a tumour to form.

"The treatments currently available to treat medulloblastoma are surgery, radiation, and chemotherapy. At times, the adverse effects of each of these therapies can be devastating to the child’s brain. This discovery is exciting because it gives us a specific target for the development of novel pharmaceuticals, or possibly the prevention of medulloblastoma," said Dr. James Rutka, co-principal investigator of the study, an HSC neurosurgeon and senior scientist, and co-director of the Arthur and Sonia Labatt Brain Tumour Research Centre.

"Our next approach will be to restore normal SUFU gene function to medulloblastoma cells to determine if this arrests tumour growth. We will also look at small molecule compounds that are known to work in the Hedgehog signaling pathway that could potentially be used as a therapy for medulloblastoma," added Dr. Rutka, holder of the Dan Family Chair in Neurosurgery and professor and chairman of the Division of Neurosurgery at U of T.

"Our findings have implications beyond childhood brain tumours," said Dr. David Hogg, a cancer geneticist who is co-principal investigator of the study. Dr. Hogg is an oncologist at Princess Margaret Hospital and an associate professor of Medicine and Medical Biophysics at U of T. "The same signaling pathways that are damaged in medulloblastomas are also disrupted in other cancers. We are now examining the role of SUFU in additional tumour types. An understanding of the genetics of human malignancy should allow us to design more effective treatments."

Dr. Hogg added: "I am very grateful for the hard work performed by Dr. Ling Liu, the senior postdoctoral fellow in my laboratory. She and Michael Taylor have put out a tremendous piece of work in a very short time."


This research was supported by the National Cancer Institute of Canada with funds from the Canadian Cancer Society and The Terry Fox Foundation, the Michael Young Melanoma Fund, the Canadian Institutes of Health Research, Brainchild, the Neurosurgery Research and Education Foundation, and The Hospital for Sick Children Foundation.

The Hospital for Sick Children, affiliated with the University of Toronto, is the largest paediatric academic health science centre in Canada and one of the largest in the world. Its mission is to provide the best in family-centred, compassionate care, to lead in scientific and clinical advancement, and to prepare the next generation of leaders in child health. For more information, please visit www.sickkids.ca.

University Health Network is a major landmark in Canada’s healthcare system and a teaching hospital of the University of Toronto. Building on the strengths and reputation of each of our three hospitals, Toronto General Hospital, Toronto Western Hospital and Princess Margaret Hospital, the network brings together the talent and resources that make it an international leader in healthcare.

The University of Toronto, Canada’s leading research university with 58,000 students, is celebrating its 175th anniversary in 2002. On March 15, 1827, King’s College - precursor to the University of Toronto - was granted its royal charter by King George IV. The university now comprises 31 divisions, colleges and faculties on three campuses, including 14 professional faculties, numerous research centres and Canada’s largest university library system - the third largest research library in North America.

For more information, please contact:

Janet Wong, Public Affairs University of Toronto (416) 978-5949 jf.wong@utoronto.ca

Vince Rice, Public Affairs University Health Network (416) 946-4501 ext. 5771 vince.rice@uhn.on.ca


Laura Greer | EurrekAlert

More articles from Health and Medicine:

nachricht The genes are not to blame
20.07.2018 | Technische Universität München

nachricht Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>